
Glenmark Generics filed a draft red herring prospectus (DRHP) yesterday, according to the sources. Glenmark Pharma would raise Rs 575 crore via Glenmark Generics initial public offer (IPO). The issue values Glenmark Generics at Rs 5,000 crore. This is sourced based information and we get to hear that, the company will raise Rs 575 crore through the IPO in Glenmark Generics. This values Glenmark Generics at about USD 1 billion or Rs 5,000 crore, the equity dilution in Glenmark Pharma is expected to be between .....
Continue Reading →

Thinksoft Global Services has extended its initial public offering (IPO) closing date to October 1, 2009 from the earlier decided date, September 24, due to a lukewarm response from investors, especially qualified institutional investors (QIBs). It also reduced its IPO price band to Rs 115-125 from the earlier Rs 120-130 per share. Commenting on this development, Asvini Kumar, MD, Thinksoft Global Services, said till yesterday QIBs had not contributed much whereas the high networth individuals (HNI) portion was oversubscribed twice and the retail portion was .....
Continue Reading →